{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:57:50Z","timestamp":1777777070182,"version":"3.51.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation","doi-asserted-by":"publisher","award":["FR-22-9689"],"award-info":[{"award-number":["FR-22-9689"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.leukres.2026.108169","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:02:48Z","timestamp":1770397368000},"page":"108169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expression and signaling patterns of CD180\/MD-1 and CD150 in Chronic Lymphocytic Leukaemia (CLL) cells"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-0454","authenticated-orcid":false,"given":"Tamar","family":"Tsertsvadze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-4909","authenticated-orcid":false,"given":"Kurtis","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7130-9812","authenticated-orcid":false,"given":"Sarah","family":"John-Olabode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7706-3048","authenticated-orcid":false,"given":"Irina","family":"Datikashvili-David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5586-6645","authenticated-orcid":false,"given":"Ani","family":"Bilanishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5999-9558","authenticated-orcid":false,"given":"John","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-9104","authenticated-orcid":false,"given":"Emanuela V.","family":"Volpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9749-8949","authenticated-orcid":false,"given":"Peter M.","family":"Lydyard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-7513","authenticated-orcid":false,"given":"Nina","family":"Porakishvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2026.108169_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajh.27546","article-title":"Chronic lymphocytic leukemia: 2025 update on the epidemiology, pathogenesis, diagnosis, and therapy","volume":"100","author":"Hallek","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108169_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2141.2005.05775.x","article-title":"Differential expression of CD180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes","volume":"131","author":"Porakishvili","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2026.108169_bib3","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2011.08605.x","article-title":"CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells","volume":"153","author":"Porakishvili","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2026.108169_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2119\/molmed.2014.00265","article-title":"Rewiring of sIgM-mediated intracellular signaling through the CD180 Toll-like receptor","volume":"21","author":"Porakishvili","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.leukres.2026.108169_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185940","article-title":"The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling","volume":"12","author":"Gordiienko","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.leukres.2026.108169_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4149\/neo_2021_210104N8","article-title":"CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells","volume":"68","author":"Shcherbina","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.leukres.2026.108169_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.17680","article-title":"Expression patterns of CD180 in the lymph nodes of patients with chronic lymphocytic leukaemia","volume":"195","author":"Edwards","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2026.108169_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107540","article-title":"MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL","volume":"143","author":"Edwards","year":"2024","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2026.108169_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI83013","article-title":"SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response","volume":"126","author":"Bologna","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2026.108169_bib10","series-title":"Understanding the biology of CD180 in chronic lymphocytic leukemia [dissertation]","author":"Edwards","year":"2024"},{"key":"10.1016\/j.leukres.2026.108169_bib11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood.V99.5.1699","article-title":"Requirement for MD-1 in cell surface expression of RP105\/CD180 and B-cell responsiveness to lipopolysaccharide","volume":"99","author":"Nagai","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108169_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ni1280","article-title":"Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA","volume":"7","author":"Barton","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.leukres.2026.108169_bib13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31768\/2312-8852.2017.39(4):291-298","article-title":"CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells","volume":"39","author":"Gordiienko","year":"2017","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.leukres.2026.108169_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/geno.1996.0632","article-title":"Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64)","volume":"38","author":"Miura","year":"1996","journal-title":"Genomics"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:44:11Z","timestamp":1777488251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":14,"alternative-id":["S0145212626000135"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108169","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and signaling patterns of CD180\/MD-1 and CD150 in Chronic Lymphocytic Leukaemia (CLL) cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108169"}}